Moreover, to exclude off-target effects of sh-USP5, a rescue experiment was performed in RA-FLSs using a target gene expression vector containing silent mutations (altering the base sequence of the shRNA binding site without changing the amino acid coding). This evidence concerns the gene USP5 and rheumatoid arthritis.